Consolidated Statement of Changes in Stockholders' Equity (Deficiency) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance, Shares (in shares) at Mar. 31, 2014	64,939,537
Balance at Mar. 31, 2014	$ 32,470	$ 32,298,094	$ (32,343,251)	$ (12,687)
Net income			358,790	$ 358,790
Balance, Shares (in shares) at Mar. 31, 2015	64,939,537			64,939,537
Balance at Mar. 31, 2015	$ 32,470	32,298,094	(31,984,461)	$ 346,103
Net income			1,118,338	$ 1,118,338
Balance, Shares (in shares) at Mar. 31, 2016	67,008,492			67,008,502
Balance at Mar. 31, 2016	$ 33,504	33,195,759	(30,866,123)	$ 2,363,140
Stock based compensation		598,699		598,699
Advanced Plasma Therapies stock purchase (in shares)	2,068,955
Advanced Plasma Therapies stock purchase	$ 1,034	$ 298,966		$ 300,000